Healthcare startup Capital Rx seeing revenue surge as Congress seeks to regulate the PBM giants that profit from high drug ...

Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...

While Trump's tariffs could have a broad impact on healthcare prices, it is likely they will not have the devastating result ...

The son-in-law of a Mexican drug lord entered a guilty plea over an 11-year price-fixing scheme that used deadly force along ...

Robin Fields ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as ...

Verona Pharma (NASDAQ:VRNA – Free Report) had its price target hoisted by Canaccord Genuity Group from $44.00 to $72.00 in a research note published on Wednesday,Benzinga reports. They currently have ...

The start of Donald Trump’s second presidency and Republican control in the 119th Congress raises questions about the future ...

The Centers for Medicare and Medicaid Services (CMS) and pharmaceutical drug manufacturers are gearing up for the second ...

Shares of Pharma-Bio Serv, Inc. (OTCMKTS:PBSV – Get Free Report) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.58 and traded as high ...

The state refuted the argument that its prescription drug pricing transparency law compels pharmaceutical companies to disclose trade secrets.

Biogen’s disappointing Leqembi performance and weak pipeline hurt future growth. Learn why BIIB stock is rated "sell" due to ...

The next round of Medicare's historic drug price negotiations could save billions for seniors taking medications like Ozempic and Wegovy.